{
    "organizations": [],
    "uuid": "0b32717c739d2f35950c8fc5fa888a62bdce2ceb",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-citius-announces-enrollment-of-fir/brief-citius-announces-enrollment-of-first-patient-in-mino-lok-late-stage-trial-idUSASB0C5YD",
    "ord_in_thread": 0,
    "title": "BRIEF-Citius Announces Enrollment Of First Patient In Mino-Lok Late Stage Trial",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 15 (Reuters) - Citius Pharmaceuticals Inc:\n* CITIUS ANNOUNCES ENROLLMENT OF FIRST PATIENT IN THE MINO-LOKâ„¢ PHASE 3 TRIAL\n* CITIUS PHARMACEUTICALS - WHEN FULLY-RECRUITED, PLANNED THERE WILL BE 700 PATIENTS ENROLLED IN 50 PARTICIPATING INSTITUTIONS, THROUGHOUT U.S IN TRIAL Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-15T21:19:00.000+02:00",
    "crawled": "2018-02-16T16:45:42.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "citius",
        "pharmaceutical",
        "inc",
        "citius",
        "announces",
        "enrollment",
        "first",
        "patient",
        "phase",
        "trial",
        "citius",
        "pharmaceutical",
        "planned",
        "patient",
        "enrolled",
        "participating",
        "institution",
        "throughout",
        "trial",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}